Lactoferrin-modified PEGylated liposomes loaded with doxorubicin for targeting delivery to hepatocellular carcinoma

References

• FornerALlovetJMBruixJHepatocellular carcinomaLancet201237998221245125522353262
   PubMed Web of Science ®Google Scholar
• LlovetJMBurroughsABruixJHepatocellular carcinomaLancet200336293991907191714667750
   PubMed Web of Science ®Google Scholar
• VarelaMSalaMLlovetJMBruixJTreatment of hepatocellular carcinoma: is there an optimal strategyCancer Treat Rev20032929910412670452
   PubMed Web of Science ®Google Scholar
• ThomasMBO’BeirneJPFuruseJChanATAbou-AlfaGJohnsonPSystemic therapy for hepatocellular carcinoma: cytotoxic chemotherapy, targeted therapy and immunotherapyAnn Surg Oncol20081541008101418236117
   PubMed Web of Science ®Google Scholar
• Abou-AlfaGKVenookAPThe impact of new data in the treatment of advanced hepatocellular carcinomaCurr Oncol Rep200810319920518765149
   PubMed Web of Science ®Google Scholar
• YeoWMokTSZeeBA randomized phase III study of doxorubicin versus cisplatin/interferon alpha-2b/doxorubicin/fluorouracil (PIAF) combination chemotherapy for unresectable hepatocellular carcinomaJ Natl Cancer Inst200597201532153816234567
   PubMedGoogle Scholar
• WangQZhongYJYuanJPTargeting therapy of hepatocellular carcinoma with doxorubicin prodrug PDOX increases anti-metastatic effect and reduces toxicity: a preclinical studyJ Transl Med20131119223961994
   PubMed Web of Science ®Google Scholar
• ChenXDingGGaoQA human anti-c-Met Fab fragment conjugated with doxorubicin as targeted chemotherapy for hepatocellular carcinomaPLoS One201385e6309323675455
   PubMed Web of Science ®Google Scholar
• AllenTMCullisPRLiposomal drug delivery systems: from concept to clinical applicationsAdv Drug Deliv Rev2013651364823036225
   PubMed Web of Science ®Google Scholar
• BozzutoGMolinariALiposomes as nanomedical devicesInt J Nanomedicine20151097599925678787
   PubMed Web of Science ®Google Scholar
• ZhouXZhangMYungBLactosylated liposomes for targeted delivery of doxorubicin to hepatocellular carcinomaInt J Nanomedicine201275465547423093902
   PubMed Web of Science ®Google Scholar
• YuKFZhangWQLuoLMThe antitumor activity of a doxorubicin loaded, iRGD-modified sterically-stabilized liposome on B16-F10 melanoma cells: in vitro and in vivo evaluationInt J Nanomedicine201382473248523885174
   PubMed Web of Science ®Google Scholar
• D’SouzaAADevarajanPVAsialoglycoprotein receptor mediated hepatocyte targeting – strategies and applicationsJ Control Release201520312613925701309
   PubMed Web of Science ®Google Scholar
• MishraNYadavNPRaiVKEfficient hepatic delivery of drugs: novel strategies and their significanceBiomed Res Int2013201338218424286077
   PubMed Web of Science ®Google Scholar
• McAbeeDDBennattDJLingYYIdentification and analysis of a CA(2+)-dependent lactoferrin receptor in rat liver. Lactoferrin binds to the asialoglycoprotein receptor in a galactose-independent mannerAdv Exp Med Biol19984431131219781350
   PubMed Web of Science ®Google Scholar
• McAbeeDDJiangXWalshKBLactoferrin binding to the rat asialoglycoprotein receptor requires the receptor’s lectin propertiesBiochem J2000348Pt 111311710794721
   PubMedGoogle Scholar
• WardPPUribe-LunaSConneelyOMLactoferrin and host defenseBiochem Cell Biol20028019510211908649
   PubMed Web of Science ®Google Scholar
• PathakAVyasSPGuptaKCNano-vectors for efficient liver specific gene transferInt J Nanomedicine200831314918488414
   PubMed Web of Science ®Google Scholar
• Weeke-KlimpAHBartschMMorseltHWTargeting of stabilized plasmid lipid particles to hepatocytes in vivo by means of coupled lactoferrinJ Drug Target200715958559417968712
   PubMed Web of Science ®Google Scholar
• OhSTRihJKKwonHSHwangDSKimSYYimJBLactoferrin as a gene delivery vehicle to hepatocytesExp Mol Med1997292111116
   Web of Science ®Google Scholar
• WeiMXuYZouQHepatocellular carcinoma targeting effect of PEGylated liposomes modified with lactoferrinEur J Pharm Sci201246313114122369856
   PubMed Web of Science ®Google Scholar
• LiSDHuangLNanoparticles evading the reticuloendothelial system: role of the supported bilayerBiochim Biophys Acta20091788102259226619595666
   PubMed Web of Science ®Google Scholar
• EvjenTJHagtvetENilssenEABrandlMFossheimSLSonosensitive dioleoylphosphatidylethanolamine-containing liposomes with prolonged blood circulation time of doxorubicinEur J Pharm Sci201143431832421620968
   PubMed Web of Science ®Google Scholar
• YingXWenHLuWLDual-targeting daunorubicin liposomes improve the therapeutic efficacy of brain glioma in animalsJ Control Release2010141218319219799948
   PubMed Web of Science ®Google Scholar
• LiXXuHDaiXZhuZLiuBLuXEnhanced in vitro and in vivo therapeutic efficacy of codrug-loaded nanoparticles against liver cancerInt J Nanomedicine201275183519023055730
   PubMed Web of Science ®Google Scholar
• LuoLMHuangYZhaoBXAnti-tumor and anti-angiogenic effect of metronomic cyclic NGR-modified liposomes containing paclitaxelBiomaterials20133441102111423127332
   PubMed Web of Science ®Google Scholar
• CuiJLiCWangCDevelopment of pegylated liposomal vincristine using novel sulfobutyl ether cyclodextrin gradient: is improved drug retention sufficient to surpass DSPE-PEG-induced drug leakage?J Pharm Sci201110072835284821305545
   PubMed Web of Science ®Google Scholar
• ZhaoWZhuangSQiXRComparative study of the in vitro and in vivo characteristics of cationic and neutral liposomesInt J Nanomedicine201163087309822163162
   PubMed Web of Science ®Google Scholar
• XieHZhuYJiangWLactoferrin-conjugated superparamagnetic iron oxide nanoparticles as a specific MRI contrast agent for detection of brain glioma in vivoBiomaterials201132249550220970851
   PubMed Web of Science ®Google Scholar
• XuZChenLGuWThe performance of docetaxel-loaded solid lipid nanoparticles targeted to hepatocellular carcinomaBiomaterials200930222623218851881
   PubMed Web of Science ®Google Scholar
• MaPLiuSHuangYChenXZhangLJingXLactose mediated liver-targeting effect observed by ex vivo imaging technologyBiomaterials20103192646265420036420
   PubMed Web of Science ®Google Scholar
• YangXHongHGrailerJJcRGD-functionalized, DOX-conjugated, and 64Cu-labeled superparamagnetic iron oxide nanoparticles for targeted anticancer drug delivery and PET/MR imagingBiomaterials201132174151416021367450
   PubMed Web of Science ®Google Scholar
• XiangYLiangLWangXWangJZhangXZhangQChloride channel-mediated brain glioma targeting of chlorotoxin-modified doxorubicine-loaded liposomesJ Control Release2011152340241021435361
   PubMed Web of Science ®Google Scholar
• JungSHJungSHSeongHChoSHJeongKSShinBCPolyethylene glycol-complexed cationic liposome for enhanced cellular uptake and anticancer activityInt J Pharm20093821–225426119666094
   PubMed Web of Science ®Google Scholar
• ChenHQinYZhangQLactoferrin modified doxorubicin-loaded procationic liposomes for the treatment of gliomasEur J Pharm Sci2011441–216417321782939
   PubMed Web of Science ®Google Scholar
• BitzerMLauerUBaumannCSpiegelMGregorMNeubertWJSendai virus efficiently infects cells via the asialoglycoprotein receptor and requires the presence of cleaved F0 precursor proteins for this alternative route of cell entryJ Virol1997717548154869188621
   PubMed Web of Science ®Google Scholar
• MuHLinKXZhaoHIdentification of biomarkers for hepatocellular carcinoma by semiquantitative immunocytochemistryWorld J Gastroenterol201420195826583824914343
   PubMed Web of Science ®Google Scholar
• dos SantosTVarelaJLynchISalvatiADawsonKAEffects of transport inhibitors on the cellular uptake of carboxylated polystyrene nanoparticles in different cell linesPLoS One201169e2443821949717
   PubMed Web of Science ®Google Scholar
• QuanGPanXWangZLactosaminated mesoporous silica nanoparticles for asialoglycoprotein receptor targeted anticancer drug deliveryJ Nanobiotechnology201513725643602
   PubMed Web of Science ®Google Scholar
• FröhlichEThe role of surface charge in cellular uptake and cytotoxicity of medical nanoparticlesInt J Nanomedicine201275577559123144561
   PubMed Web of Science ®Google Scholar
• KirchnerCLiedlTKuderaSCytotoxicity of colloidal CdSe and CdSe/ZnS nanoparticlesNano Lett20055233133815794621
   PubMed Web of Science ®Google Scholar
• LeeTKLauTCNgIODoxorubicin-induced apoptosis and chemosensitivity in hepatoma cell linesCancer Chemother Pharmacol2002491788611855756
   PubMed Web of Science ®Google Scholar
• LiTTakeokaSEnhanced cellular uptake of maleimide-modified liposomes via thiol-mediated transportInt J Nanomedicine201492849286124940060
   PubMed Web of Science ®Google Scholar
• CaiLWangXWangWPeptide ligand and PEG-mediated long-circulating liposome targeted to FGFR overexpressing tumor in vivoInt J Nanomedicine201274499451022923988
   PubMed Web of Science ®Google Scholar
• HwangTHanHDSongCKAnticancer drug-phospholipid conjugate for enhancement of intracellular drug deliveryMacromol Symp20072492501109115
   Google Scholar
• TagamiTErnstingMJLiSDEfficient tumor regression by a single and low dose treatment with a novel and enhanced formulation of thermosensitive liposomal doxorubicinJ Control Release2011152230330921338635
   PubMed Web of Science ®Google Scholar